Literature DB >> 3652011

Optic gliomas. A reanalysis of the University of California, San Francisco experience.

J Y Wong1, V Uhl, W M Wara, G E Sheline.   

Abstract

Thirty-eight cases of optic gliomas seen at the University of California, San Francisco, were reviewed. Two patients died in the postoperative period and were excluded from the follow-up analysis. Twenty-nine cases (76%) involved the optic chiasm, nine (24%) cases were confined to one optic nerve. Most tumors were slow growing and progressive although there were three cases of adult chiasmal gliomas which exhibited unusually aggressive behavior. The three cases are presented in detail. After a mean follow-up period of 9.4 years, the 10-year overall actuarial survival was 87%. Relapse-free survival was 55% at 10 years. Chiasmal tumors had a poorer prognosis compared to optic nerve tumors with 56% of chiasmal tumors recurring versus 22% of optic nerve tumors. Radiotherapy was beneficial in chiasmal gliomas, initially improving vision in 35% (6/17) and decreasing recurrence from 86% (6/7) without radiation therapy to 45% (9/20) with radiation therapy. Optic gliomas are not benign, self-limiting lesions, and therefore require treatment. Radiotherapy is effective in chiasmal gliomas and should be used early in the management of these tumors. No advantage to radiotherapy could be demonstrated for optic nerve gliomas, although the number of these cases analyzed was small.

Entities:  

Mesh:

Year:  1987        PMID: 3652011     DOI: 10.1002/1097-0142(19871015)60:8<1847::aid-cncr2820600829>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

Authors:  L Kornreich; S Blaser; M Schwarz; A Shuper; T H Vishne; I J Cohen; R Faingold; S Michovitz; B Koplewitz; G Horev
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Visual pathway glioma: an erratic tumour with therapeutic dilemmas.

Authors:  A Shuper; G Horev; L Kornreich; S Michowiz; R Weitz; R Zaizov; I J Cohen
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 3.  Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature.

Authors:  Manolo Piccirilli; Jacopo Lenzi; Catia Delfinis; Guido Trasimeni; Maurizio Salvati; Antonino Raco
Journal:  Childs Nerv Syst       Date:  2006-04-26       Impact factor: 1.475

Review 4.  Malignant optic glioma - the spectrum of disease in a case series.

Authors:  Ghislaine L Traber; Athina Pangalu; Manuela Neumann; Joao Costa; Michael Weller; Ruth Huna-Baron; Klara Landau
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

Review 5.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

6.  Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).

Authors:  K Müller; A Gnekow; F Falkenstein; J Scheiderbauer; I Zwiener; T Pietsch; M Warmuth-Metz; J Voges; G Nikkhah; M Flentje; S E Combs; D Vordermark; M Kocher; R-D Kortmann
Journal:  Strahlenther Onkol       Date:  2013-07-07       Impact factor: 3.621

7.  Optic nerve glioma and the management of optic nerve tumours in the young.

Authors:  J E Wright; A A McNab; W I McDonald
Journal:  Br J Ophthalmol       Date:  1989-12       Impact factor: 4.638

8.  Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.

Authors:  Kavita K Mishra; Sarah Squire; Kathleen Lamborn; Anuradha Banerjee; Nalin Gupta; William M Wara; Michael D Prados; Mitchel S Berger; Daphne A Haas-Kogan
Journal:  J Neurooncol       Date:  2010-03-11       Impact factor: 4.130

Review 9.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

10.  Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas.

Authors:  J M Valdueza; F Lohmann; O Dammann; C Hagel; B Eckert; N Freckmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.